Lack of influence of the ACE1 gene I/D polymorphism on the formation and growth of benign uterine leiomyoma in turkish patients

Asian Pacific Journal of Cancer Prevention

Volumn 16, Issue 3, 2015, Pages 1123-1127

  Gültekin, Güldal Inal ^a   Yilmaz, Seda Güleç ^b   Kahraman, Özlem Timirci ^a   Atasoy, Hande ^b   Burak Dalan, A ^b   Attar, Rukset ^b   Büyükören, Ahmet ^c   Uçunoglu, Nazli ^b   Isbir, Turgay ^b  

^a Institute for Experimental Medicine Research   (Turkey)

^b YEDITEPE UNIVERSITY   (Turkey)

^c ISTANBUL UNIVERSITY   (Turkey)

Author keywords

ACE insertion deletion; Angiogenesis; Benign cancer; Uterine fibroid; Uterine myoma

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE;

ADULT; CANCER STAGING; CASE CONTROL STUDY; COMPARATIVE STUDY; ENZYMOLOGY; FEMALE; FOLLOW UP; GENE FREQUENCY; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETICS; GENOTYPE; HUMAN; LEIOMYOMA; MALE; NORMAL HUMAN; PATHOLOGY; POLYMERASE CHAIN REACTION; PROGNOSIS; RISK FACTOR; TURKEY;

ADULT; CASE-CONTROL STUDIES; FEMALE; FOLLOW-UP STUDIES; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HEALTHY VOLUNTEERS; HUMANS; LEIOMYOMA; MALE; NEOPLASM STAGING; PEPTIDYL-DIPEPTIDASE A; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; PROGNOSIS; RISK FACTORS; TURKEY;

EID: 84929380395     PISSN: 15137368     EISSN: None     Source Type: Journal    
DOI: 10.7314/APJCP.2015.16.3.1123     Document Type: Article

References (44)

1. Alvarez R, Terrados N, Ortolano R, et al (2000). Genetic variation in the renin-angiotensin system and athletic performance. Eur J Appl Physiol, 82, 117-120.
2. Ates O, Demirturk F, Toprak M, et al (2013). Polymorphism of catechol-o-methyltransferase and uterine leiomyoma. Mol Cell Biochem, 375, 179-83.
3. Baird DD, Dunson DB, Hill MC, et al (2000). High cumulative incidence of uterine leiomyoma in black and white women: ultrasound evidence. Am J Obstet Gynecol, 188, 100-7.
4. Bayram B, Kilicci C, Onlu H, et al (2011). Association of angiotensin converting enzyme (ACE) gene I/D polymorphism and polycystic ovary syndrome (PCOS). Gene, 489, 86-8.
5. Cardozo ER, Clark AD, Banks NK, et al (2012). The estimated annual cost of uterine leiomyomata in the United States. Am J Obstet Gynecol, 206, 1-9.
6. Catherino WH, Eltoukhi HM, Al-Hendy A (2013). Racial and ethnic differences in the pathogenesis and clinical manifestations of uterine leiomyoma. Semin Reprod Med, 31, 370-9.
7. Cha PC, Takahashi A, Hosono N, et al (2011). A genome-wide association study identifies three loci associated with susceptibility to uterine fibroids. Nat Genet, 43, 447-50.
8. Cheng Z, Ma R, Tan W, et al (2014). Lack of association between ACE insertion/deletion polymorphism and lung cancer: A meta-analysis. J Renin Angiotensin Aldosterone Syst, [Epub ahead of print].
9. Di Lieto A, De Falco M, Pollio F, et al (2005). Clinical response, vascular change, and angiogenesis in gonadotropin-releasing hormone analogue-treated women with uterine myomas. J Soc Gynecol Investig, 12, 123-8.
10. Dinh DT, Frauman AG, Johnston CI, et al (2001). Angiotensin receptors: distribution, signaling and function. Clin Sci (Lond), 100, 481-92.
11. Edwards TL, Michels KA, Hartmann KE, et al (2013). BET1L and TNRC6B associate with uterine fibroid risk among European Americans. Hum Genet, 132, 943-53.
12. Ekin M., Cengiz H, Ozturk E, et al (2014). Genitourinary symptoms and their effects on quality of life in women with uterine myomas. Int Urogynecol J, 25, 807-10.
13. Ergen HA, Hatemi H, Agachan B, et al (2004). Angiotensin-I converting enzyme gene polymorphism in Turkish type 2 diabetic patients. Exp Mol Med, 36, 345-50.
14. Fernandez LA, Twickler J, Mead A (1985). Neovascularization produced by angiotensin II. J Lab Clin Med, 105, 141-5.
15. Fishchuk LE, Gorovenko NG (2013). Genetic polymorphisms of the renin-angiotensin system in breast cancer patients. Exp Oncol, 35, 101-4.
16. Flake GP, Andersen J, Dixon D (2003). Etiology and pathogenesis of uterine leiomyomas: a review. Environ Health Perspect, 111, 1037-54.
17. Freitas-Silva M, Pereira D, Coelho C, et al (2004). Angiotensin I-converting enzyme gene insertion/deletion polymorphism and endometrial human cancer in normotensive and hypertensive women. Cancer Genet Cytogenet, 155, 42-6.
18. Gülec-Yilmaz S, Yilmaz H, Dalan AB, et al (2014). The relationship between ACE polymorphism and panic disorder. In Vivo, 28, 885-9.
19. Hakverdi S, Demirhan O, Tunc E, et al (2013). Chromosome imbalances and alterations in the p53 gene in uterine myomas from the same family members: familial leiomyomatosis in Turkey. Asian Pac J Cancer Prev, 14, 651-8.
20. Henskens LH, Spiering W, Stoffers HE, et al (2003). Effects of ACE I/D and AT1R-A1166C polymorphisms on blood pressure in a healthy normotensive primary care population: first results of the hippocates study. J Hypertens, 21, 81-6.
21. Herr D, Bekes I, Wulff C (2013). Local renin-angiotensin system in the reproductive system. Front Endocrinol, 4, 1-7.
22. Hsieh YY, Lee CC, Chang CC, et al (2007). Angiotensin I-converting enzyme insertion-related genotypes and allele are associated with higher susceptibility of endometriosis and leiomyoma. Mol Reprod Dev, 74, 808-14.
23. Isbir SC, Tekeli A, Ergen A, et al (2007). Genetic polymorphisms contribute to acute kidney injury after coronary artery bypass grafting. Heart Surg Forum, 10, 439-44.
24. Jia H, Wang B, Yu L, et al (2013). Association of angiotensin-converting enzyme gene insertion/deletion polymorphism with polycystic ovary syndrome: a meta-analysis. J Renin Angiotensin Aldosterone Syst, 14, 255-62.
25. Li XL, Zheng ZJ, Qu HO (2014). Lack of association of angiotensin-converting enzyme insertion/deletion polymorphism with breast cancer: An update meta-analysis based on 10405 subjects. J Renin Angiotensin Aldosterone Syst, [Epub ahead of print].
26. Li ZH Pan XM, Han BW, et al (2012). No association between ACE polymorphism and risk of nasopharyngeal carcinoma. J Renin Angiotensin Aldosterone Syst, 13, 210-5.
27. Liu SY, Sima X, Wang CH, et al (2011). The association between ACE polymorphism and risk of colorectal cancer in a Chinese population. Clin Biochem, 44, 1223-6.
28. Matsumoto T, Sagawa N, Mukoyama M, et al (1996). Type 2 angiotensin II receptor is expressed in human myometrium and uterine leiomyoma and is down-regulated during pregnancy. J Clin Endocrinol Metab, 81, 4366-72.
29. Mc Menamin UC, Murray LJ, Cantwell MM, et al (2012). Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in cancer progression and survival: a systematic review. Cancer Causes Control, 23, 221-30.
30. Rigat B, Hubert C, Alhenc-Gelas F, et al (1990). An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. J Clin Invest, 86, 1343-6.
31. Rigat B, Hubert C, Corvol P, et al (1992). PCR detection of the insertion/deletion polymorphism of the human angiotensin converting enzyme gene (DCP1) (dipeptidyl carboxypeptidase. Nucleic Acids Res, 20, 1433.
32. Risau W (1997). Mechanisms of angiogenesis. Nature, 386, 671-4.
33. Rocken C, Neumann K, Carl-McGrath S, et al (2007). The gene polymorphism of the angiotensin I-converting enzyme correlates with tumor size and patient survival in colorectal cancer patients. Neoplasia, 9, 716-22.
34. Shen Y, Ren ML, Xu J, et al (2014). A multicenter case-control study on screening of single nucleotide polymorphisms in estrogen-metabolizing enzymes and susceptibility to uterine leiomyoma in han chinese. Gynecol Obstet Invest, 77, 224-30.
35. Tal R, Segars JH (2014). The role of angiogenic factors in fibroid pathogenesis: potential implications for future therapy. Hum Reprod Update, 20, 194-216.
36. The National Center for Biotechnology Information. http://www.ncbi.nlm.nih.gov/gene/1636. Accessed January 2015.
37. Timmermans PB, Wong PC, Chiu AT, et al (1993). Angiotensin II receptors and angiotensin II receptor antagonists. Pharmacol Rev, 45, 205-51.
38. Vairaktaris E, Serefoglou Z, Avgoustidis D, et al (2009). Gene polymorphisms related to angiogenesis, inflammation and thrombosis that influence risk for oral cancer. Oral Oncol, 45, 247-53.
39. van der Knaap R, Siemes C, Coebergh JW, et al (2008). Renin-angiotensin system inhibitors, angiotensin I-converting enzyme gene insertion/deletionpolymorphism, and cancer: the Rotterdam Study. Cancer, 112, 748-57.
40. Verit FF, Yucel O (2013). Endometriosis, leiomyoma and adenomyosis: the risk of gynecologic malignancy. Asian Pac J Cancer Prev, 14, 5589-97.
41. Wei MT, Chen N, He YZ, et al (2014). Angiotensin-converting enzyme insertion/deletion polymorphism and gastric cancer: A systematic review and meta-analysis. Clin Res Hepatol Gastroenterol, [Epub ahead of print].
42. Yapijakis C, Koronellos N, Spyridonidou S, et al (2013). Association of angiotensin-converting enzyme gene insertion/deletion polymorphism with decreased risk for basal cell carcinoma. Arch Dermatol Res, 305, 333-9.
43. Yuan F, Zhang LS, Li HY, et al (2013). Influence of angiotensin I-converting enzyme gene polymorphism on hepatocellular carcinoma risk in China. DNA Cell Biol, 32, 268-73.
44. Zhang K, Cheng D, Yi L, et al (2014). Association between angiotensin I-converting enzyme gene polymorphism and susceptibility to cancer: a meta analysis. Int J Clin Exp Pathol, 7, 6291-300.